genotype

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt
Gamal Shiha, Gamal Esmat, Mohamed Hassany, Reham Soliman, Mohamed Elbasiony, Rabab Fouad, Aisha Elsharkawy, Radi Hammad, Wael Abdel-Razek, Talaat Zakareya, Kathryn Kersey, Benedetta Massetto, Anu Osinusi, Sophia Lu, Diana M Brainard, John G McHutchison, Imam Waked, Wahid Doss

Gut Apr 2018, gutjnl-2017-315906; DOI: 10.1136/gutjnl-2017-315906
In vitro and in silico evidence against a significant effect of the SPINK1 c.194G>A variant on pre-mRNA splicing
Hao Wu, Arnaud Boulling, David N Cooper, Zhao-Shen Li, Zhuan Liao, Jian-Min Chen, Claude Férec

Gut Dec 2017, 66 (12) 2195-2196; DOI: 10.1136/gutjnl-2017-313948
Toward chronic hepatitis C eradication in HIV-positive patients, including those cirrhotic and infected with genotype 3 viruses
Amélie Menard, Sarah Aherfi, Saadia Mokhtari, Catherine Dhiver, Isabelle Ravaux, Hervé Tissot-Dupont, Line Meddeb, Philippe Brouqui, Andreas Stein, Philippe Colson

Gut Oct 2017, 66 (10) 1868-1869; DOI: 10.1136/gutjnl-2016-313431
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study
Tania M Welzel, David R Nelson, Giuseppe Morelli, Adrian Di Bisceglie, Rajender K Reddy, Alexander Kuo, Joseph K Lim, Jama Darling, Paul Pockros, Joseph S Galati, Lynn M Frazier, Saleh Alqahtani, Mark S Sulkowski, Monika Vainorius, Lucy Akushevich, Michael W Fried, Stefan Zeuzem

Gut Oct 2017, 66 (10) 1844-1852; DOI: 10.1136/gutjnl-2016-311609
Reply: ‘More viral mutants, less HBsAg clearance? One size may not fit all'
Alex Thompson, Stephen Locarnini, Peter Revill

Gut Aug 2017, 66 (8) 1534-1535; DOI: 10.1136/gutjnl-2016-313287
PWE-003 Mdm2 t309g polymorphism and risk of colorectal cancer
N Aggarwal, ND Donald, S Malik, SS Selvendran, M McPhail, KJ Monahan

Gut Jul 2017, 66 (Suppl 2) A126-A127; DOI: 10.1136/gutjnl-2017-314472.248
PWE-002 The association of low penetrance variants in dna repair genes with colorectal cancer: a systematic review and meta-analysis
N Aggarwal, ND Donald, S Malik, SS Selvendran, M McPhail, KJ Monahan

Gut Jul 2017, 66 (Suppl 2) A126; DOI: 10.1136/gutjnl-2017-314472.247
Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver
Ibrahim M Sayed, Lieven Verhoye, Laurence Cocquerel, Florence Abravanel, Lander Foquet, Claire Montpellier, Yannick Debing, Ali Farhoudi, Czeslaw Wychowski, Jean Dubuisson, Geert Leroux-Roels, Johan Neyts, Jacques Izopet, Thomas Michiels, Philip Meuleman

Gut May 2017, 66 (5) 920-929; DOI: 10.1136/gutjnl-2015-311109
Siblings of patients with Crohn’s disease exhibit a biologically relevant dysbiosis in mucosal microbial metacommunities
Charlotte Hedin, Christopher J van der Gast, Geraint B Rogers, Leah Cuthbertson, Sara McCartney, Andrew J Stagg, James O Lindsay, Kevin Whelan

Gut Jun 2016, 65 (6) 944-953; DOI: 10.1136/gutjnl-2014-308896
The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design
Annette von Delft, Isla S Humphreys, Anthony Brown, Katja Pfafferott, Michaela Lucas, Paul Klenerman, Georg M Lauer, Andrea L Cox, Silvana Gaudieri, Eleanor Barnes

Gut Jan 2016, 65 (1) 112-123; DOI: 10.1136/gutjnl-2014-308724

Main menu

genotype

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

genotype

Pages